Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2019 | A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing miR-34a and deregulating the DRD4/Akt/mTOR signaling axis | Wen, YT; Wu, ATH; Bamodu, OA; Wei, L; Lin, CM; Yen, Y; Chao, TY; Mukhopadhyay, D; Hsiao, M ; Huang, HS | Cancers 11(10), 1442 | | | |
2021 | A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling | Wu, ATH; Huang, HS; Wen, YT; Lawal, B; Mokgautsi, N; Huynh, TT; Hsiao, M ; Wei, L | CELLS 10(9), 2391 | | | |
2014 | Pharmacologic Down-regulation of EZH2 Suppresses Bladder Cancer in vitro and in vivo | Tang, SH; Huang, HS; Wu, HU; Tsai, YT; Chuang, MJ; Yu, CP; Huang, SM; Sun, GH; Chang, SY; Hsiao, PW; Yu, DS; Cha, TL | Oncotarget 5(21), 10342-10355 | | | |